🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Harshita B. Gupta

The University of Texas at San Antonio Health Science Center

ORCID: 0000-0003-1003-2658

Also affiliated with The University of Texas at San Antonio

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Pharmacological tumor PDL1 depletion with chlorambucil treats ovarian cancer and melanoma: improves antitumor immunity and renders anti-PDL1-resistant tumors anti-PDL1-sensitive through NK cell effects”.

Pharmacological tumor PDL1 depletion with chlorambucil treats ovarian cancer and melanoma: improves antitumor immunity and renders anti-PDL1-resistant tumors anti-PDL1-sensitive through NK cell effects

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2022-004871
N/A
0.385DataRank · unranked
12 citations

Álvaro Padrón, Yilun Deng, Yiji Liao, Clare J Murray, Carlos Ontiveros +9 more

Anti-PD-L2 immunotherapy is efficacious against melanoma in aged hosts through IL-17 and IFNγ signalling

Nature Communications(2025)10.1038/s41467-025-65025-2
N/A
0.165DataRank · unranked
2 citations

Myrna Garcia, Clare Murray, Yilun Deng, Haiyan Bai, Christopher Tanner +17 more

234 Distinct efficacy and immunological responses to αPD-1, αPD-L1 and αPD-L2 immunotherapy in aged versus young hosts

Regular and Young Investigator Award Abstracts(2021)10.1136/jitc-2021-sitc2021.234
N/A
0DataRank · unranked
0 citations

Harshita B. Gupta, Myrna Garcia, Aravind Kancharla, Ryan M. Reyes, Álvaro Padrón +2 more

Immune checkpoint expression and relationships to anti‐PD‐L1 immune checkpoint blockade cancer immunotherapy efficacy in aged versus young mice

Aging and Cancer(2022)10.1002/aac2.12045
N/A
0DataRank · unranked
29 citations

Yilun Deng, Clare Murray, Ryan M. Reyes, Álvaro Padrón, Haiyan Bai +5 more

Bladder cancer cell‐intrinsic PD‐L1 signals promote mTOR and autophagy activation that can be inhibited to improve cytotoxic chemotherapy

Cancer Medicine(2021)10.1002/cam4.3739
N/A
0DataRank · unranked
47 citations

Ryan M. Reyes, Erica Osta, Suresh Kari, Harshita B. Gupta, Álvaro Padrón +10 more

Tumour-intrinsic PDL1 signals regulate the Chk2 DNA damage response in cancer cells and mediate resistance to Chk1 inhibitors

Molecular Cancer(2024)10.1186/s12943-024-02147-z
N/A
0DataRank · unranked
11 citations

Anand Kornepati, Carlos Ontiveros, Yiji Liao, Bárbara de la Peña Avalos, Cody M. Rogers +25 more

Targeting N-Myc in neuroblastoma with selective Aurora kinase A degraders

Cell chemical biology(2025)10.1016/j.chembiol.2024.12.006
N/A
0DataRank · unranked
23 citations

Ramkumar Moorthy, Laura Hirsch, Özlem Demir, Zachary D. Baker, Jordan A. Naumann +12 more

1428 Melanocyte-intrinsic PDL1 promotes tumorigenesis and progression in a novel autochthonous melanoma model

Regular and Young Investigator Award Abstracts(2022)10.1136/jitc-2022-sitc2022.1428
N/A
0DataRank · unranked
0 citations

Yilun Deng, Anand Kornepati, Clare Murray, Mary Jo Turk, Harshita B. Gupta +3 more

CD122-directed interleukin-2 treatment mechanisms in bladder cancer differ from αPD-L1 and include tissue-selective γδ T cell activation

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2020-002051
N/A
0DataRank · unranked
22 citations

Yilun Deng, Deyi Zhang, Niannian Ji, Neelam Mukherjee, Karen Wheeler +11 more